Occasionally, we see objections to antiviral drugs, especially those targeting broad spectrum efficacy, based on the idea that viruses can be beneficial to human life. Usually however, these objections rest on a straw man: including viruses which attack bacteria (known…
Before covid-19 burst into our lives and onto our screens in 2019, the word ‘pandemic’ was not part of the daily vocabulary. It’s quite possible that I’ve never even used the word during my 46 years on this planet. Now,…
Media Release – 28 November 2022 Nelson biotech company Kimer Med is expanding into a new laboratory and looking to hire additional staff after signing an agreement with Cawthron Institute this week. The move means Kimer Med will now be…
More than 3,000 people die every day from liver disease caused by viral hepatitis, and today (July 28) is World Hepatitis Day. What is World Hepatitis Day? World Hepatitis Day is an annual opportunity to raise awareness about the suffering…
There are a few questions that seem to come up with almost every extended conversation about Kimer Med and what we’re doing. This isn’t meant to be an investor disclosure document, or anything like that; it’s just an informal discussion…
With a broad-spectrum antiviral such as VTose, one of the most common questions we get is whether it will work on particular viruses. The short answer is that we won’t know for sure until we test. However, based on the…
Let’s start with how human cells normally defend themselves against viruses. One way this works is through antibodies. These large, Y-shaped proteins are produced by plasma B cells, a type of white blood cell. Antibodies attach to certain pathogens, effectively…